diclofenac has been researched along with cj-023,423 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, MJ; Chambers, M; Chandrasekhar, S; Fisher, MJ; Harvey, A; Lin, C; Mudra, D; Oskins, J; Vetman, T; Wang, XS; Warshawsky, AM; Yu, XP | 1 |
| Blanco, MJ; Chambers, M; Chandrasekhar, S; Fisher, MJ; Harvey, A; Kuklish, SL; Lin, C; Mudra, D; Oskins, J; Vetman, T; Wang, XS; Warshawsky, AM; Yu, XP | 1 |
2 other study(ies) available for diclofenac and cj-023,423
| Article | Year |
|---|---|
Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.
Topics: Animals; Benzoic Acid; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Half-Life; Humans; Inhibitory Concentration 50; Pain; Picolines; Protein Binding; Rats; Receptors, Prostaglandin E, EP4 Subtype; Structure-Activity Relationship | 2016 |
Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists.
Topics: Animals; Benzoates; Rats; Receptors, Prostaglandin E, EP4 Subtype; X-Ray Diffraction | 2016 |